1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

AML - 849

Prevalence of Standard Modifiable Risk Factors and Associated Cardiovascular Events Among Patients Hospitalized With Acute Myeloid Leukemia: A Nationwide Inpatient Analysis (2016-2022)

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

Thumbnail for Prevalence, Mortality, and Healthcare Utilization in Hemophagocytic Lymphohistiocytosis Among Lymphoma Patients: Insights From the NIS Database

ABCL - 1385

Prevalence, Mortality, and Healthcare Utilization in Hemophagocytic Lymphohistiocytosis Among Lymphoma Patients: Insights From the NIS Database

Srijani Thannir

Poster Presenter: Srijani Thannir

AML - 1755

Preventable Leukemia in the Workplace: Global Burden of Occupational Benzene-Attributable Leukemia, 1990–2023

Hardik Jain

Poster Presenter: Hardik Jain

HL - 671

Primary Bone Marrow Hodgkin Lymphoma in Adults: A Systematic Review of Clinical Features, HIV/EBV Associations, and HLH Overlap

Anthony Navarrete Rios

Poster Presenter: Anthony Navarrete Rios

Thumbnail for Primary Central Nervous System Lymphoma in Latin America: Real-World Clinicopathological Characteristics and Survival Outcomes From a National Reference Center

ABCL - 095

Primary Central Nervous System Lymphoma in Latin America: Real-World Clinicopathological Characteristics and Survival Outcomes From a National Reference Center

Amairani Carpintero Diaz

Poster Presenter: Amairani Carpintero Diaz

Thumbnail for Primary Outcomes from the Phase 3 Study of Tafasitamab (Tafa) Plus Lenalidomide (Len) and R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) (frontMIND)

ABCL - 489

Primary Outcomes from the Phase 3 Study of Tafasitamab (Tafa) Plus Lenalidomide (Len) and R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) (frontMIND)

Jason Westin

Poster Presenter: Jason Westin

Video

Thumbnail for Primary Prophylaxis With Immunoglobulin Replacement Therapy Is Associated With Lower Cumulative Infection Burden and Healthcare Utilization in Patients With Multiple Myeloma Receiving BCMA-Directed BsAbs

MM - 647

Primary Prophylaxis With Immunoglobulin Replacement Therapy Is Associated With Lower Cumulative Infection Burden and Healthcare Utilization in Patients With Multiple Myeloma Receiving BCMA-Directed BsAbs

Patricia Lugar

Poster Presenter: Patricia Lugar

$Thumbnail for Prior Bendamustine Exposure Within 12 Months and Outcomes After CAR-T or Bispecific Antibody Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Real-World Analysis$

ABCL - 1313

Prior Bendamustine Exposure Within 12 Months and Outcomes After CAR-T or Bispecific Antibody Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Real-World Analysis

Archit Srivastava

Poster Presenter: Archit Srivastava

AML - 208

Profile and Treatment Outcomes of Filipino Acute Myeloid Leukemia Patients Managed at a Tertiary Institution: A Single-Center, 10-Year Retrospective Study

Roanne Ilano

Poster Presenter: Roanne Ilano